title: Fatal outcome in two girls with hodgkin disease complicating ataxia-telangiectasia (Louis-Bar syndrome) despite favorable response to modified-dose chemotherapy.
authors.affiliation: Department of Pediatrics, Heinrich-Heine-University, Düsseldorf, Germany. kruck@uni-duesseldorf.de
authors.forename: H
authors.initials: H
authors.lastname: Irsfeld
authors.forename: D
authors.initials: D
authors.lastname: Körholz
authors.forename: G
authors.initials: G
authors.lastname: Janssen
authors.forename: V
authors.initials: V
authors.lastname: Wahn
authors.forename: H
authors.initials: H
authors.lastname: Schroten
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001260:Ataxia Telangiectasia / Q000150:complications* / Q000235:genetics; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins; D002648:Child; D002675:Child, Preschool; D004268:DNA-Binding Proteins; D004305:Dose-Response Relationship, Drug; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007223:Infant; D009154:Mutation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D025521:Tumor Suppressor Proteins
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases